- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06563453
Implication of Cognitive Reserve in Non-pharmacological Intervention Outcomes
Cognitive reserve (CR) is defined as the gradual accumulation of neural resources and their adaptability (i.e., efficiency, capacity, flexibility) due to genetic and/or lifelong environmental factors that mitigate the cognitive effects of age-related processes and brain diseases. Transcranial alternating current stimulation (tACS) can be used to entrain underlying neuronal networks, promoting firing at specific frequencies. Recent studies have demonstrated that fronto-parietal theta oscillatory activity entrainment via tACS leads to working memory enhancement in healthy subjects. However, there remains significant variability in stimulation-induced aftereffects across individuals.
Emerging literature suggests that individual differences, such as CR levels, may be crucial in predicting the benefits of treatment interventions, as they reflect available neural capacity and flexibility. A novel interventional approach is proposed to study CR, utilizing both conventional static proxies, such as premorbid intellect and educational attainment, and dynamic markers, including pupillometry, resting-state, and task-induced functional MRI. By employing cutting-edge noninvasive brain stimulation (NIBS) techniques, the study will acutely modulate network properties to examine the influence of CR on immediate cognitive and brain functional aftereffects induced by the intervention. In addition to focusing on cognitively healthy older adults, this study will, for the first time, include patients with mild cognitive impairment with Lewy bodies (MCI-LB), a prodromal stage of the second most common degenerative dementia after Alzheimer's disease.
Study Overview
Status
Intervention / Treatment
Detailed Description
A novel interventional approach is proposed for studying cognitive reserve (CR) using dynamic biomarkers, including:
Neuromelanin-sensitive MRI sequences to evaluate signal intensity of the locus coeruleus, Resting-state functional MRI (rs-fMRI) to evaluate network properties such as modularity and local and global efficiency, Baseline dynamic rs-fMRI to evaluate mean dwell time and number of transitions between states, and Baseline task-induced activation to evaluate engagement of "domain-specific" and "domain-general" regions during the 'offline' transfer working memory (WM) task performance, i.e., tasks solved after transcranial alternating current stimulation (tACS).
These dynamic biomarkers are used in addition to established conventional static proxies (education and premorbid intellect).
Specifically, the study aims to:
Assess which CR biomarkers and conventional CR proxies, alone or in combination, best predict the tACS-induced magnitude of cognitive enhancement of the 'online' WM task (solved while stimulated).
Evaluate the influence of CR on the recruitment of compensatory mechanisms (as assessed by task-induced fMRI and rs-fMRI) induced by tACS for solving challenging WM tasks.
Investigate how the CR level moderates the relationship between the magnitude and spatial patterns of brain flexibility changes induced by an acute tACS (as measured by pupil dilation during the online WM task performance and pre-post tACS resting-state functional connectivity changes within and between large-scale brain networks) and cognitive tACS-induced enhancement (as measured by 'online' WM task performance and changes in the 'offline' transfer task performance solved after stimulation).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kristina Mitterova, Ph.D.
- Phone Number: 735512163
- Email: kristina.mitterova@ceitec.muni.cz
Study Locations
-
-
-
Brno, Czechia, 62500
- Recruiting
- CEITEC Masaryk University
-
Contact:
- Kristina Mitterova, Ph.D.
- Phone Number: 735512163
- Email: kristina.mitterova@ceitec.muni.cz
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Intact cognitive performance as assessed by cognitive evaluation.
- Subjects with possible or probable mild cognitive impairment with Lewy bodies (MCI-LB).
Exclusion Criteria:
Presence of dementia as assessed by a cognitive test battery and evaluation of daily activities.
Any major psychiatric disorder. History of neurological disease affecting the central nervous system (e.g., tumor, epilepsy, stroke, etc.).
Severe or repeated head injury. Non-compensated internal or oncological disease. MRI-incompatible metal in the body (e.g., pacemaker). Left-handedness.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: sham stimulation
Two inactive electrodes (anodes and cathodes) - placed over Medial frontal lobe and Inferior parietal lobe.
The flow of current discontinues after 20 seconds, the stimulation continues.
|
Transcranial Alternating Current Stimulation (tACS) is a tool that administers a weak alternating current (in the range of 0.1 to 4 mA), most often with a sinusoidal waveform, between electrodes placed over target areas.
This can entrain the subjacent neuronal networks favouring the firing at specific frequencies of interest, in certain cases, with effects outlasting the stimulation duration up to 70 min.
|
|
Experimental: frontal stimulation
One active electrode (anode and cathode) - placed over Medial frontal lobe, one inactive electrode (anode and cathode) - placed over Inferior parietal lobe. Current intensity - 2 (milliamperes) mA, frequency: theta 4.51 Hz, stimulation time: 20 minutes |
Transcranial Alternating Current Stimulation (tACS) is a tool that administers a weak alternating current (in the range of 0.1 to 4 mA), most often with a sinusoidal waveform, between electrodes placed over target areas.
This can entrain the subjacent neuronal networks favouring the firing at specific frequencies of interest, in certain cases, with effects outlasting the stimulation duration up to 70 min.
|
|
Experimental: frontoparietal stimulation
One active electrode (anode and cathode) - placed over Medial frontal lobe, another active electrode (anode and cathode) - placed over Inferior parietal lobe. Current intensity - 2 mA, frequency: theta 4.51 Hz in-phase, stimulation time: 20 minutes |
Transcranial Alternating Current Stimulation (tACS) is a tool that administers a weak alternating current (in the range of 0.1 to 4 mA), most often with a sinusoidal waveform, between electrodes placed over target areas.
This can entrain the subjacent neuronal networks favouring the firing at specific frequencies of interest, in certain cases, with effects outlasting the stimulation duration up to 70 min.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy and reaction times of the visual N-back task in tACS conditions:tACS conditions
Time Frame: 3.5 years
|
'Online' working memory (WM) task accuracy and reaction times (RT) in both active and sham tACS conditions. tACS conditions |
3.5 years
|
|
Accuracy and reaction times of the verbal N-back task in tACS conditions: tACS conditions
Time Frame: 3.5 years
|
'Offline' WM task accuracy and reaction times (RT) in both active and sham tACS conditions. tACS conditions |
3.5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive reserve moderator:
Time Frame: 3.5 years
|
Identification of which cognitive reserve proxies or indexes are most effective at moderating tACS-induced changes.
|
3.5 years
|
|
tACS-induced functional connectivity changes:
Time Frame: 3.5 years
|
tACS-induced neural changes, including resting-state functional connectivity (rs-FC) within and between large-scale brain networks, dynamic rs-fMRI measures, and task-induced BOLD (Blood-Oxygen-Level Dependent) signal increases assessed at baseline and immediately after each stimulation.
|
3.5 years
|
|
Pupillary changes
Time Frame: 3.5
|
Measures of pupil dilation during the N-back task performance.
|
3.5
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ilona Eliášová, Ph.D., Masaryk university
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NU21-04-00652
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Florida Institute for Human and Machine CognitionNot yet recruitingAging | Healthy Aging | Aging WellUnited States
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
University of CopenhagenRecruitingAging | Healthy Aging | Aging FrailtyDenmark
-
Radboud University Medical CenterTerminated
-
Northwestern UniversityPotocsnak Human Longevity LabRecruitingAging | Aging Well | Aging, Biological | Aging, HealthyUnited States
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAging | Aging, HealthyFrance
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
Arizona State UniversityActive, not recruiting
-
San Diego State UniversityCompleted
Clinical Trials on transcranial alternating current stimulation
-
Central South UniversityRecruitingAttention-Deficit/Hyperactivity DisorderChina
-
QVITI S.A.CompletedStroke | AphasiaPoland
-
Anhui Medical UniversityRecruitingNon-suicidal Self-injury | Depression DisordersChina
-
I.R.C.C.S. Fondazione Santa LuciaActive, not recruitingAlzheimer DiseaseItaly
-
Universidad Metropolitana de Ciencias de la EducacionCompletedRehabilitation | Chronic StrokeChile
-
Anhui Provincial HospitalNot yet recruitingDementia | Mild Cognitive Impairment | Alzheimer's Disease
-
First Affiliated Hospital of Zhejiang UniversityRecruitingConsciousness DisordersChina
-
A.J.C. SlooterRadboud University Medical Center; HagaZiekenhuisRecruiting
-
Anhui Medical UniversityRecruitingEarly Alzheimer's Disease | Electroencephalography | Transcranial Alternating Current StimulationChina
-
Anhui Medical UniversityRecruitingMagnetic Resonance Imaging | Anxiety Disorder | Transcranial Alternating Current StimulationChina